Talis Biomedical to Announce Second Quarter 2021 Financial Results on August 10, 2021

Rhea-AI Summary

Talis Biomedical Corporation (TLIS) will release its second quarter financial results on August 10, 2021, after market close. A conference call will follow at 1:30 p.m. Pacific Time to discuss these results. The company is focused on developing innovative molecular diagnostic tests for infectious diseases, starting with COVID-19. Talis One, its primary product, aims to provide accurate and rapid testing at the point-of-care. Interested parties can access the call via telephone or through a live webcast on Talis' investor page.

Positive

• Company focused on developing innovative molecular diagnostic tests.
• Talis One offers rapid molecular testing at the point-of-care.

Negative

• None.

MENLO PARK, Calif., July 27, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today announced that it will release financial results for the second quarter after market close on Tuesday, August 10, 2021. Talis will host a conference call, beginning at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss financial and operational results.

Interested parties may access the live call via telephone by dialing 833-715-1329 for participants in the U.S. or Canada and 430-775-1933 for international callers, using conference ID 5966606. A live and archived webcast of the event can be accessed via the News & Events page of the investor section of Talis Biomedical’s website at www.talis.bio.

About Talis Biomedical
Talis is dedicated to transforming diagnostic testing by developing and commercializing innovative products that are designed to enable accurate, low cost and rapid molecular testing for infectious diseases at the point-of-care, beginning with COVID-19. The company is developing Talis One, a compact, sample-to-answer, cloud-enabled, molecular diagnostic platform. Talis is headquartered in Menlo Park, California. For more information, please visit talis.bio.

Contact
Media & Investors
Emily Faucette
ir@talisbio.com
415-595-9407

FAQ

When will Talis Biomedical Corporation release their Q2 financial results?

Talis Biomedical Corporation will release their Q2 financial results on August 10, 2021, after market close.

What time is the Talis conference call for financial results?

The Talis conference call for financial results will begin at 1:30 p.m. Pacific Time on August 10, 2021.

How can I access the Talis financial results conference call?

You can access the Talis financial results conference call by dialing 833-715-1329 in the U.S. or Canada, and 430-775-1933 for international callers. A live webcast is also available on their investor website.

What is Talis Biomedical's focus in diagnostics?

Talis Biomedical is dedicated to developing and commercializing molecular diagnostic tests, particularly for infectious diseases like COVID-19.